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NORMAL PRESSURE HYDROCEPHALUS: HOW CAN IT BE TOLD APART 
FROM NEURODEGENERATIVE DISEASES OF THE ELDERLY? 
Raphael C. Zohn 
ABSTRACT 
Normal pressure hydrocephalus (NPH) affects more of the older population than people 
recognize. The underestimation of this neurological condition is due in most part to the overlap 
of its symptoms to other forms of dementia as well as many other geriatric conditions. The 
objective of this paper was to research and contrast various methods of differentiation in the 
diagnosis of normal pressure hydrocephalus as well as find pretreatment indicators of successful 
surgery. Methods included reviewing of articles and studies done to evaluate which symptoms 
are most commonly presented in normal pressure hydrocephalus and their subtle differences 
from the symptoms of other neurodegenerative diseases. There are also comparisons of different 
theories as to the prevalence of normal pressure hydrocephalus and which, if any, symptoms are 
indicative of a correct diagnosis. Conclusions were as follows: there are guidelines, although 
controversial, that can be followed in trying to distinguish normal pressure hydrocephalus; there 
are some symptoms that are better prognosticators of successful surgery than others, and while 
surgery is often followed by the subsequent relapse of symptoms, this is possibly due to the 
comorbidity of other disorders with normal pressure hydrocephalus. Surgery should therefore be 
approached cautiously while weighing the risks versus the benefits. Normal pressure 
hydrocephalus seems to be fairly prevalent and when appropriate, some older people might be 
able to reverse their symptoms. 
INTRODUCTION 
If an elderly man were to walk into his doctor’s office complaining of walking 
difficulties, urinary incontinence, as well as having trouble with memory and hard thinking, the 
doctor might initially presume the man has Alzheimer’s disease. Upon further review, he would 
be greatly mistaken. Extensive testing can lead to a drastic change in the diagnosis. Intermittently 
elevated levels of cerebrospinal fluid (CSF) pressure in the lateral ventricles of the brain along 
with ventriculomegaly (enlargement of the ventricles without a noticeable amount of cortical 
atrophy) would tell the doctor that the man is suffering from hydrocephalus. Unfortunately, this 
example is very common. Despite the fact that a patient might be presenting the abovementioned 
classic clinical triad of symptoms for hydrocephalus, errors all too likely. Normal pressure 
hydrocephalus (NPH) is a subcategory of communicating hydrocephalus, one of the four main 
categories of the disease. NPH has primary (idiopathic) and secondary (known) causes. 
Secondary causes include complications following head trauma, subarachnoid hemorrhage, 
meningitis, brain tumor, or previous neurosurgical procedures. While people of all ages are 
affected by secondary NPH (sNPH), idiopathic NPH (iNPH) distinguishes itself as a disease of 
the elderly. About 50% of NPH cases are idiopathic and half come from a known event. When 
most think of hydrocephalus, the swelled head of a child comes to mind. Few realize how 
widespread iNPH is and that many older patients suffer from it. Many doctors don’t even notice 
it and diagnose it as something else. However, if caught early on, iNPH can be treated with a 
much greater chance of success. The problem arises when it comes to pinpointing all the 
characteristics of iNPH that can aid in its diagnosis. Its symptoms are not specific to the 
diagnosis and occur commonly in many other neurodegenerative conditions, such as Parkinson’s 
and Alzheimer’s disease (Klassen and Ahlskog 2011). Furthermore, it is often comorbid with 
other neurological disorders that are actually present in geriatric patients. This doubt makes it 
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difficult to elect for surgery and is the primary reason why 80% of cases of hydrocephalus go 
unrecognized and untreated (Kiefer and Unterberg 2012). Studies done on its prevalence, along 
with case studies and accounts show that it is far more common than would appear at first glance 
due mainly to mistakes and the fact there is little awareness of its commonality. The very fact 
that iNPH is believed to be uncommon, leads to false diagnoses, which in turn causes skewed 
statistics. While this disease is perceived to be rare, attempts to identify all patients with iNPH 
overlook a large number of cases (Conn 2011).  This paper will explore just how prevalent it is, 
as well as discuss literature on ways it can be better recognized and diagnosed. Studies indicate 
that certain symptoms are more indicative of iNPH than others. There are many characteristics of 
NPH that are specific to it, and can aid in its diagnosis.  How can we differentiate a potentially 
reversible disorder from the more common forms of dementia? 
BACKGROUND OF NPH 
HISTORY 
The first mention of hydrocephalus dates back all the way to 2500 BC where references 
can be found in ancient Egyptian medical literature. It was not until 1000 AD, however, that an 
operative procedure was performed. An Arab surgeon at that point in time clearly describes the 
removal of spare cerebrospinal fluid from the skulls of hydrocephalic children. He writes that 
“the volume of the skull then increases daily, so that the bones of the skull fail to close” (Aschoff 
et al. 1999). A real treatment for the condition did not enter the scene until the 20th century when 
shunts and other neurosurgical procedures became popular.  The first description of NPH came 
in 1965 when a small group of patients presented with various neurological symptoms, 
ventricular enlargement, and what looked like normal cerebrospinal fluid pressure during lumbar 
puncture. After shunting, their symptoms improved (Vacca 2007).  The shunt treatment does not 
fully heal the patient though, and, to this day, there is no complete cure. 
ANATOMICAL DEFINITION 
Hydrocephalus can be broadly defined as an abnormal expansion of the lateral ventricles 
in the brain caused by an accumulation of cerebrospinal fluid. Cerebrospinal fluid cushions the 
brain and spinal cord in the subarachnoid space between the arachnoid and pia maters that cover 
them. Cerebrospinal fluid is produced by specialized capillaries known as the choroid plexus. 
Cerebrospinal fluid flows from the two lateral ventricles through their respective foramina of 
Monro into the third ventricle. From there it passes through the aqueduct of Sylvius into the 
fourth ventricle, which is located in the posterior fossa, and then the central canal of the spinal 
cord. It enters the space in between the meninges through small openings in the ventricular 
system and covers the brain and spine, acting as a cushion and protecting the brain from shock. 
From the subarachnoid space, cerebrospinal fluid is absorbed by clusters of arachnoid villi, 
sometimes called arachnoid granulations, close to the top of the brain, and eventually drains into 
the venous system from the superior sagittal sinus (Tortora and Derrickson 2006). The 
cerebrospinal fluid in a normally functioning person flows around the superior sagittal sinus and 
gets reabsorbed by the arachnoid villi due to pressure gradient differential. When cerebrospinal 
fluid is being blocked at any point during this flow cycle, it causes the ventricles in the brain to 
get stretched and become enlarged, affecting portions of subcortical brain tissue as well as white 
matter. There is approximately a pint of cerebrospinal fluid produced in the brain each day and 
the turnover rate of the cerebrospinal fluid is more than three times a day. However, because the 
production of the fluid is independent of the absorption, a lack of absorption results in an 
accumulation of cerebrospinal fluid in the ventricles (See Figure 1). 
 
77
Raphael C. Zohn 
 
Figure 1: Anatomy of the ventricle 
system. Source: National 
Fibromyalgia Research 
Association 
 
ETIOLOGY 
There are several different types of hydrocephalus.   
Some are born with it, while others develop it much later in 
life. It can be genetic or acquired through physical or 
mental trauma. It can make one’s head swell up like a 
balloon or shrink the brain in some cases. There are 
different causes for hydrocephalus and thus several 
different categories. Reasons could be either disrupted flow 
of the fluid, a problem with reabsorbing the fluid, or too 
much production. The most common is flow obstruction. 
There are four main categories of hydrocephalus: 
congenital, acquired, non-communicating, and 
communicating. NPH is a form of communicating 
hydrocephalus meaning there is no obstruction in the actual 
pathway and is therefore extremely difficult to detect. The 
etiology of NPH is unclear. While some cases can be 
attributed to known neurological injuries like subarachnoid 
hemorrhage and meningitis, most are idiopathic. Its 
symptoms most likely are due to ventricular dilation. The 
leading theory behind this dilation is the lack of 
reabsorption of cerebrospinal fluid into the venous system. 
Others suggest that the cerebral vasculature may have a role in the pathogenesis of NPH 
(Siedlecki 2008). Although the intracranial pressure gradient increases between the fluid in the 
subarachnoid space and the ventricles, it remains normal. It is this increasing pressure that leads 
to cerebral ischemia and a stretching of the periventricular white matter. Scarring and fibrosis on 
the arachnoid granulations can disrupt the absorption of cerebrospinal fluid. 
DIAGNOSIS 
NPH is characterized by the chronic elevation of intracranial pressure due to increased 
cerebrospinal fluid becoming stable and therefore not exhibiting some of the usual hydrocephalic 
symptoms, such as headaches, vomiting, nausea, or altered consciousness. The big three 
symptoms, referred to as the Hakim triad after the doctor who first described them, include gait 
impairment, cognitive dysfunction, and urinary incontinence. NPH can be considered when the 
triad of symptoms is present. All three symptoms, however, are not required to suspect NPH. In 
the past, NPH would be diagnosed only if presenting the complete triad. Now, however, it can be 
diagnosed and treated in the presence of only two cardinal symptoms or even just one. This 
change in attitude resulted from the recognition that the longer NPH remains untreated, the 
worse the prognosis gets, with the complete triad always signifying an advanced stage of the 
disease (Kiefer and Unterberg 2012). Typically, gait impairment occurs first, with cognitive 
impairment and urinary incontinence occurring later. The difficulty with gait is usually described 
as a shuffling or magnetic walk and an exaggerated wide stance. It is also usually first to improve 
after shunt surgery. If left untreated, gait may deteriorate until the patient can no longer walk and 
is limited to a wheel chair. Dementia, when present, is subcortical. Cortical dementia, such as 
Alzheimer’s has characteristics such as severe memory loss, an inability to recall words and 
understand common language. In contrast, subcortical dementia presents as inattention, latency 
in recall, and lack of spontaneity (slowness in response and reaction). These are known as abulic 
traits (Byrd 2006). The urinary disorder associated with NPH starts with urinary frequency or 
78
NORMAL PRESSURE HYDROCEPHALUS 
 
urgency and then develops into complete loss of bladder control in the later stages of the disease. 
Incontinence often will not appear in early stages, and may go unreported as patients will 
attribute it to other prostatic issues and normal aging. It is also possible that what is chalked up to 
incontinence is merely an inability to reach the bathroom because of the slowed gait. These three 
clinical manifestations are likely caused by pressure on the structures adjacent to the ventricles. 
For example, pressure on the frontal lobes and their interconnections, including structures such 
as the limbic system, may cause symptoms of dementia. Pressure on the cortical center for 
bladder control may be the reason for incontinence, and pressure on the corticospinal tract, 
whose fibers lateral to the ventricles supply motor function to the legs, may cause the gait 
disturbance. The fibers of the corticospinal tract passing closest to the lateral ventricles in the 
corona radiate may be the reason why gait is first to improve. 
The earlier on NPH is diagnosed, the more reversible it seems to be. Physical 
examination, assessment of cortical and subcortical function, and careful analysis of gait, along 
with a complete record of previous health, are the most important tools used in diagnosing NPH. 
Diagnoses aren’t simple because these symptoms overlap with other disorders. Today, 
radiographic imaging studies are used as the main determining factor. In patients with clinical 
features of NPH, CT scans or MRIs should be used to measure ventricular size, rule out 
ventricular obstruction, and look for other possible causes like tumors, infections, and structural 
abnormalities. Diagnostic guidelines for monitoring symptoms have been published to pick out 
probable NPH patients from the possible (Siedlecki 2008). Screening of prospective surgery 
candidates is done to decide if shunt surgery would successfully reverse their symptoms. There 
have been conflicting reports as to the effectiveness of shunting procedures. However, 
cerebrospinal fluid monitoring and a trial of controlled, continuous cerebrospinal fluid drainage 
of 150-200mL per day has proven to make diagnoses more accurate (McGirt et al. 2005). 
Invasive diagnosis includes a spinal tap test: lumbar puncture with the removal of 30 to 70 mL of 
cerebrospinal fluid. This can be repeated for two or three days in a row. Modern forms of 
treatment lead to improvement in 70-90% of patients according to some studies (Kiefer and 
Unterberg 2012). 
TREATMENT 
The foremost method of treatment is the surgical installment of a ventriculoperitoneal 
shunt, a tube that connects the ventricles of the brain to an alternate drainage site, usually the 
abdominal cavity. A small hole is made in the skull and a catheter is placed in one of the lateral 
ventricles. It is then tunneled subcutaneously behind the ear and down to the abdominal cavity. 
The shunt contains a cap and valve ensuring there is no back-flow. In a way, some non-
communicating hydrocephalic patients have an advantage because the only issue is the blockage 
of the subarachnoid space. In such cases, the shunt need only bypass that blockade and can 
empty into the subarachnoid space. Patients that have shunts implanted need life-long monitoring 
to ensure that it is doing its job and there is no recurring hydrocephalus. Shunt surgery is a very 
invasive procedure and is not without risk. Included in these risks are hemorrhage and stroke. 
There are some drugs that help delay the need for surgery: acetazolamide, furocemide, and 
digoxin, to name a few. Symptoms tend to improve upon removing the excess fluid at least for 
the short-term. It has been found to be the most effective available treatment for NPH. It is 
believed that shunting improves symptoms by removing the pressure from the parenchymal 
absorption pathway at the areas of the ventricles where cerebrospinal fluid is produced, reducing 
interstitial swelling and pressure, which then reduces ischemia. 
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iNPH 
Hydrocephalus is special in that it is one of the few reversible causes of dementia. iNPH 
mainly affects people over 60 years of age. The big problem with iNPH is that it goes unnoticed 
and thereby untreated in many cases. Folks who think there is no cure for their dementia would 
be shocked to find out that it may actually be quite reversible. Diagnosis is made very difficult 
by the fact that there is overlap with many other diseases of the elderly and the surgery is quite 
invasive and can create complications. Often, after surgical implantation of a shunt, the 
symptoms will return, leading to questions whether NPH was the problem to begin with. It 
further complicates things when NPH is actually comorbid with some of the diseases that it is 
confused with, such as Alzheimer’s and Parkinson’s. It is estimated that more than 750,000 
Americans have NPH, but less than 20% receive an appropriate diagnosis and treatment. This is 
largely due to its misdiagnosis in the first place and it is believed that an astounding 5 to10% of 
people living with dementia, in fact have NPH (Siedlecki 2008). 
PREVALENCE 
The true prevalence of NPH is debatable. The available epidemiological data are 
inconsistent partly because there is no one set of diagnostic criteria. Moreover, 75% of those 
with NPH also have vascular dementia or Alzheimer’s disease. A study done recently in 
Germany found one person in 80 to be demented. About 250,000 people receive a new diagnosis 
of dementia each year and NPH is thought to account for about 6% of all cases of dementia. A 
study of demented patients in nursing homes found that 9% to 14% of them had the symptoms 
typical of NPH. The incidence of NPH is approximated at 0.2 to 5.5 new cases per 100,000 
people per year. Its prevalence is said to be 0.003% in patients under 65, and 0.2% to 2.9% for 
65 and up. The prevalence of NPH rises significantly with age (Kiefer and Unterberg 2012). In 
one community-based study, data suggest that real clinical and imaging features that strongly 
suggest NPH are relatively uncommon and that most patients originally suspected of having 
NPH do not respond to a cerebrospinal fluid removal trial.  The authors come to the conclusion 
that despite “relatively high prevalence figures (0.4%–14%)…studies that simply tabulate gait 
disturbance, dementia, incontinence, and ventriculomegaly without broader reference to the 
overall clinical context probably overestimate NPH prevalence” (Klassen and Ahlskog 2011). 
This is interesting because they seem to partially dismiss the triad of symptoms and 
neuroimaging showing enlarged ventricles as being indicative of NPH. Most other studies find 
that differential diagnosis based the clinical triad of symptoms and reading of imaging tests is 
more subtle. It is possible that their sample sizes are too small to be able to draw these 
conclusions from them. 
DIFFERENTIAL DIAGNOSIS 
The diagnosis of NPH and how its symptoms manifest themselves is controversial to say 
the least. Many other diseases have similar clinical characteristics to NPH, either by themselves 
or together with others. The most closely related are Alzheimer’s disease, Parkinson’s disease, 
diffuse Lewy body disease, vascular dementia, frontotemporal dementia, chronic alcoholism, 
carcinomatous meningitis, subdural hematoma, lumbar canal stenosis, and endocrine disorders 
such as hypothyroidism and Addison’s disease. It is possible that many diseases can be alternate 
causes of symptoms of NPH as well as coexist with it. For example, spinal stenosis, a gait-
associated condition, a cognition-associated condition such as subdural hematoma, and urinary 
diseases such as benign prostatic hypertrophy together at the same time in a patient and will 
appear to be NPH. The following is a contrast between the symptoms of NPH and other 
neurological disorders in numerous steps to be followed during diagnosis: 
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IMAGING AND CEREBROSPINAL FLUID STUDIES 
Features on CT scans that suggest NPH are the presence of bigger temporal horns, overly 
enlarged ventricles (ventricles tend to enlarge with age anyway), and brain tissue shrinkage. 
Ventricles enlarge with age, but if the ratio of the maximum width of the anterior ventricular 
horns to the maximum width of the calvarium is greater than 0 .3 (called the Evans ratio), the 
ventricles are considered abnormally enlarged (Factora and Luciano 2008). NPH can be 
characterized by findings on MRIs such as transependymal resorption, T2-weighted increased 
intensities in brain parenchyma next to the ventricles, and preservation of hippocampal tissue. 
Typical findings of NPH also include a coronal section at the level of the posterior commissure 
revealing a narrowed subarachnoid level surrounding the brain, called a tight convexity, and 
narrow medial cisterns. In addition to the lateral ventricles, the third ventricle is usually enlarged 
as well, while the fourth may or may not be enlarged. In addition, a higher level of cerebrospinal 
fluid flow through the aqueduct of Sylvius and a forceful cerebrospinal fluid flow through the 
foramina in the cerebrum. Spinal tap using a radionuclide isotope introduced into the 
subarachnoid space through a lumbar puncture has been one of the most used tests for 
diagnosing NPH. The test detects increased resistance to cerebrospinal fluid absorption via the 
arachnoid granulations, as seen in NPH. The standard spinal tap test collects between 20 and 50 
mL of cerebrospinal fluid, measures the opening pressure, and conducts cerebrospinal fluid 
analysis. Normal cerebrospinal fluid protein and glucose levels, white blood cell count, and an 
opening pressure in the range of 60 to 240 mm H2O, is highly suggestive of NPH. In all, there 
are six cerebrospinal fluid-related tests that can be used to figure out if NPH is present and also 
help determine if the patient is likely to respond to shunting. These include the standard spinal 
tap, large-volume spinal tap, temporary external lumbar drainage, extended intracranial 
monitoring, cerebrospinal fluid outflow assessment, and measurement of aqueductal 
cerebrospinal fluid flow (Osei-Boamah 2011). A particularly effective prognosticator of surgery 
outcome is the continuous spinal drainage of 150 to 200 mL of cerebrospinal fluid per day for 2 
to 7 days. This test is considered to be positive if the number of steps taken in a 10-meter gait 
test, and the time needed to walk 10 meters, are reduced by 20% or more and/or there is an 
improvement of at least 10% in psychometric tests. 
GAIT DYSFUNCTION 
Diseases that share similar gait symptoms with NPH include: Parkinson-plus syndromes, 
Parkinson's disease, vascular Parkinsonism, visual impairment (cataracts, glaucoma, and macular 
degeneration), lumbar canal stenosis, large joint osteoarthritis, and peripheral neuropathy 
deconditioning (Factora and Luciano 2008). How can NPH’s specific gait defects be told apart 
from the walking difficulties older people with these illnesses encounter? NPH patients initially 
complain of dizziness, trouble walking on stairs, and difficulty getting up from or sitting down 
on a chair. As the disease progresses, the patient’s gait deteriorates significantly, becoming slow, 
broad-based, short-stepped, and glue-footed. Freezing during walking and difficulty with turning 
or starting to walk also suggest disease progression. Often, as a result of these gait abnormalities, 
frequent falls will call for the need of a cane or walker. In the later stages of NPH, motor deficit 
is usually worse because of the cognitive deficits. Sometimes, it is so severe that the patient can’t 
walk at all. Of major importance for the differential diagnosis, are the following: Externally 
rotated posture of the feet, particular difficulty turning on the body’s long axis, and absence of 
apraxia (Kiefer and Unterberg 2012). This is confusing because in the past, some actually 
referred to the symptom as gait apraxia because it looks like the person has forgotten how to 
walk and has trouble with basic components of walking (DiCecco 2009; Osei-Boamah 2011; 
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Siedlecki 2008). Apraxia is a disorder of motor planning and should not be confused with ataxia, 
a lack of coordination of movement, or abulia, the lack of desire to carry out an action. One 
doctor, however, writes in his findings that the short stride, slow gait, and difficulty with turning 
present challenging similarities between the gait of NPH and that of Parkinson’s disease and 
cerebellar ataxia. Ways to help identify NPH include the absence of extrapyramidal signs such as 
cogwheel rigidity and no response to levodopa. In addition, NPH patients do not exhibit a resting 
tremor. Unlike patients with Parkinson’s disease, NPH patients do not respond to visual and 
acoustic cues. Cerebellar ataxia is different in that it has other features such as dysarthria, gaze-
evoked nystagmus, and appendicular dysmetria. NPH has none of those symptoms (Osei-
Boamah 2011).  NPH patients also have poor posture with a forward rounding of the shoulders 
and arms that hang loosely at their sides. They appear to always be watching their feet as they 
attempt to move. This limpness of the extremities is a telling sign of NPH, whereas Parkinson’s 
is usually coupled with rigidity and stiffness of the limbs and trunk (Siedlecki 2008). In addition, 
the gait with Parkinson's disease tends to be more narrow-based, and the balance problems and 
disequilibrium are not as apparent (Ropper and Brown 2005). Many believe that a detailed gait 
history is extremely important for an accurate diagnosis. Specifically, the onset of the gait 
problems should be examined. Was the onset a progressive decline or more sudden? Typically, 
gait impairment in NPH is more gradual. Did the patient exhibit symptoms of tremor or 
bradykinesia (a general slowness of movement) suggesting Parkinson’s? If the patient has back 
or cervical neck pain, it suggests the presence of lumbar canal stenosis or cervical myelopathy 
respectively (Factora and Luciano 2008).  Parkinson-plus syndromes have features such as gaze 
palsy or autonomic dysfunction in addition to the shuffling gait that reduce the likeliness of 
diagnosis of NPH. In the elderly it is more likely to have multiple etiologies for these gait 
symptoms. For example, patients who have symptoms of NPH also can have lumbar canal 
stenosis. Therefore, one should always consider which of the disorders is more likely to be the 
cause for the impeded gait. In this case, it should also be considered that lumbar canal stenosis 
can interfere with a trial of cerebrospinal fluid removal used in predicting shunt outcome in NPH 
and limit potential for improvement after shunt placement (Factora and Luciano 2006). 
COGNITIVE IMPAIRMENT 
Disorders with similar cognitive manifestations as NPH include: Alzheimer’s disease, 
diffuse Lewy body disease, vascular dementia frontal lobe dementias, depression, and prion 
disease. Cognitive impairment associated with NPH is often mild, and might initially be 
attributed to normal aging. The problems are mainly subcortical in nature. Short-term memory 
loss, short attention and concentration spans, apathy, and slow processing are some results of 
subcortical dementia. In other words, difficulty forming words, being unable to carry out simple 
tasks sequentially, or difficulty interpreting sensory stimuli are all cortical features and do not 
appear in NPH dementia. Any of these symptoms would distinguish NPH from cortical 
dementias, such as Alzheimer's disease (Byrd 2006). If other signs of cortical dementia, such as 
aphasia, agnosia, or apraxia are present, Alzheimer's disease should be considered. Dementia is 
also the dominant clinical feature of Alzheimer’s disease. Alzheimer’s and NPH can occur 
together, however, and the incidence of Alzheimer’s disease in patients with suspected NPH is 
between 33% and 50% according to one study’s estimate (Savolainen et al. 1999). Vascular 
dementia (stroke, multi-infarct dementia, vertebrobasilar insufficiency) and dementia with Lewy 
bodies are other causes of dementia to consider. Vascular dementia usually presents as a 
stepwise decline over an extended period, with greater loss of higher-order cognitive functions 
such as visuospatial perception and executive function. Lewy body dementia is especially hard to 
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tell from NPH, as it has both gait and cognitive deficits. However, its hallmarks are 
hallucinations and cognitive fluctuations which are rare in NPH patients (Johnson and Graham 
2010).When the comorbidities are associated with subcortical deficits like in vascular dementia, 
depression, and frontotemporal dementia, it is much more difficult to separate those 
characteristics that imply NPH. Table 1 shows the differences between cognitive deficits one 
comes across in NPH and the symptoms Alzheimer’s disease and vascular dementia classically 
present (Factora and Luciano 2006). The timing of the cognitive impairment’s development 
compared to that of gait is useful diagnosing NPH and determining if shunting will be successful. 
Normally dementia does not precede gait impairment in NPH, and when it does it signifies a 
weaker response to surgery. As previously discussed in regards to Alzheimer’s disease, in cases 
where dementia is the predominant feature of all symptoms, consider evaluation for another 
neurodegenerative disease (Siedlecki 2008). History of cognition in a patient plays a role as well. 
A history of slowly progressing fading of memory and other areas of cognition bad enough to 
affect daily activities supports a diagnosis of Alzheimer’s disease. These symptoms may also 
appear years after the onset of Parkinson's. A known history of strokes and a stepwise decline 
with each might mean vascular dementia. Mental status testing is used to confirm cognitive 
impairment is present and see how severe it is. The Mini-Cog and the Short Portable Mental 
Status Questionnaire are used to screen for the presence of cognitive impairment. The Folstein 
MiniMental State Examination can also be used to quantify how severe the impairment is. A 
clock-drawing test is sometimes used to assess visuospatial skills and executive function. 
Table 1: Comparison of dementia characteristics. 
Alzheimer's 
disease 
Vascular 
dementia 
Normal pressure 
hydrocephalus 
Memory impairment X X Impaired retrieval 
Executive dysfunction X X X 
Impaired visuospatial 
process 
X X
a
Impaired language X X
a
Bradyphrenia 
Impaired complex motor 
skills 
X X
a
Psychomotor slowing X 
Impaired attentiveness X 
a- Can occur based on location of infarction (tissue death) 
These are not problems present in NPH patients according to most. Use of a screening 
test such as the Geriatric Depression Scale can weed out patients with depression that can affect 
cognitive function. Neuropsychological tests can be very useful in distinguishing between the 
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cortical and subcortical dementias (Factora and Luciano 2008; Siedlecki 2008). Early 
cerebrospinal fluid shunting can improve the cognitive deficits in as many as 80% of patients 
with NPH, but improvement is far less likely if the patient also has vascular dementia or 
Alzheimer’s disease (Kiefer and Unterberg 2012). 
URINARY INCONTINENCE 
In the elderly population, incontinence is very prevalent. Causes include benign prostatic 
hypertrophy resulting in bladder outlet obstruction, retention coming from neurogenic bladder, 
either from long-standing diabetes or related to Parkinson's, pelvic relaxation that helps lead to 
stress incontinence, and cystitis. Identifying the specific type of incontinence (urge, stress, 
overflow, or functional) can help find the true cause. The use of cystoscopy and urodynamic 
testing can be used to eliminate other diagnoses (Factora and Luciano 2006). Incontinence in 
NPH comes from detrusor hyperactivity which results from absence of central inhibitory control 
but there is no evidence of defective bladder sphincter control. It starts as increased urinary 
frequency. It later develops into urge incontinence and then permanent urinary incontinence. 
Fecal incontinence is rare in NPH and points to another type of disorder. Urinary symptoms 
usually come later than the other two symptoms and are lacking entirely in some patients. In 
patients with NPH, the slow gait can compound the problem, making it difficult to reach the 
bathroom in time and can make it difficult in determining the real cause (Byrd 2006). Diuretics 
can cause urinary frequency, alpha-agonists obstruction, and some medications with 
anticholinergic side effects may produce urinary retention. Evaluation of urinary incontinence 
can target certain symptoms. A urinalysis can easily be done to exclude the presence of a urinary 
tract infection. Getting a postvoid residual can identify those with urinary retention who are 
experiencing stress symptoms or any sensation of incomplete void. Urodynamic testing to 
evaluate urge incontinence has not been helpful in distinguishing NPH from other causes of 
detrusor instability. Cerebrospinal fluid shunting can improve bladder dysfunction in as many as 
80% of NPH patients if surgery is done early on, but if performed in an advanced stage less than 
50% to 60% respond positively (Kiefer and Unterberg 2012). 
PROGNOSIS 
The prognosis for NPH depends on a variety of factors, including age of onset and timing 
of surgery. Overall, most reports say people with suspected NPH have a 50% chance of 
benefiting (for the long term) from the installation of a shunt (Longe 2006). That figure includes 
those with known causes. iNPH in particular, as previously discussed, has several indicators of 
good shunting outcome that include early diagnosis, gait as the predominant symptom, and a 
positive response to large-volume cerebrospinal fluid draining. The presence of B waves during 
the majority of continuous intracranial monitoring, cerebrospinal fluid outflow resistance of 
more than 18 mm Hg/mL/min., and increased aqueductal cerebrospinal fluid flow are also 
indicative of potential success with shunting (Osei-Boamah 2011). A study by Malm et al. 
(1995) found that the number of patients with iNPH who improved from surgical implantation of 
the ventriculoperitoneal shunt went from 64% at 3 months to 26% at 3 years. This showed that a 
shunt may be effective only temporarily, lasting from 1 to 3 years. However, shunting can still 
make an enormous difference in quality of life for many of these patients. In the short term, the 
success rate is usually reported between 50% and 90% with all patients suffering a decrease over 
the following years. The high variability in reports is likely due to differences in selection, 
method of shunting, care in following up, and how success is defined. Much failure over time is 
caused by the development or progression of other neurologic or systemic disease (Factora and 
Luciano 2008). Some reports of symptom improvement after ventriculoperitoneal shunt surgery 
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Figure 2: CT scan of ventriculomegaly 
vs. normal in adult 
are as low as 30% in patients with iNPH and 50% to 70% for patients with sNPH (Johnson and 
Graham 2010). Studies have shown that up to 93% of patients have major improvements in gait 
shortly after surgical treatment of NPH, as opposed to only 50% improving in cognitive 
symptoms (Yusim et al. 2008). Indeed, many seem to think the gait symptom is the primary 
indicator of NPH as well as ventriculomegaly (See Figure 2). In one study, among 41 patients 
with suspected NPH, all had gait dysfunction, 30 had cognitive impairment, and 14 had urinary 
incontinence. Twenty out of forty one presented with two of the symptoms, while twelve had all 
three parts of the triad. Nineteen were found to have at least moderate postural instability 
(defined by a positive pull test). All 40 patients with available results had documented 
ventriculomegaly. Only 13 of these underwent shunt placement, as it was offered only to those 
with gait improvement after a trial of cerebrospinal fluid removal, and only 4 of these had all 
elements of the classic NPH triad (Klassen and Ahlskog 2011). However, despite these positive 
symptoms, more than half did not respond well to the shunt in the long run. Of note is the fact 
that no patient with postural instability showed definite improvement after shunting, and 4 out of 
5 (not including one who died during surgery) were later given an additional diagnosis. It may be 
that this symptom is a trademark of underlying neurodegenerative disease. Shunting may not be 
the best course of action for these patients (Klassen and Ahlskog 2011). Many feel that the best 
predictor of ventriculoperitoneal shunt outcome is external lumbar drainage; it is said to be about 
85% accurate in identifying patients that would benefit from surgery, and is becoming more and 
more popular with neurosurgeons (Byrd 2006). Any surgery in the elderly population is going to 
have risks. Studies have risks as high as 30% to 40% in shunting, and severe morbidity or death 
at 6% to 8% (Factora and Luciano 2006). 
CONCLUSIONS 
NPH is a lesser-known medical condition 
for which a relatively small amount of research is 
conducted to improve treatment for. It was once 
thought that its prevalence hovered around 0.5% 
(Brean and Eide 2008). Recent studies show that it 
is closer to being between 1 and 2%. The reason 
for the discrepancy seems to be an 
oversimplification of the terminology of the 
symptoms (Conn 2011), and there do seem to be 
more subtle tells when it comes to diagnosing 
NPH.  Identifying symptoms in the triad is simple, 
but determining which patients truly have NPH 
and will benefit from shunting is not 
straightforward. Shunting outcomes are not quite related to which patients had NPH to begin 
with due to comorbidity with other diseases. Although patients need not have all three symptoms 
for NPH to be considered, the gait deficit seems the most crucial for diagnosis. The mere 
presence of enlarged ventricles does not seem to be a valid indicator as they tend to enlarge with 
age. There are multiple conflicting theories and therefore many disagreements as to the true 
symptoms of NPH. Thus, the differential diagnosis of NPH can be quite difficult. The criteria for 
a diagnosis of NPH seem clear to everyone only with the following findings that make the 
diagnosis of NPH less likely: intracranial pressure above 25 cm H2O (this rules out iNPH by 
definition), age under 40, cortical deficits, progressive dementia without gait disturbance, and 
lack of progression of symptoms. The progression of symptoms is a controversial point, as 
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authors differ on what is considered a normal time of progression. A patient is considered a 
potential ventriculoperitoneal shunt candidate if he or she has symptoms consistent with NPH 
(not explained by other diagnoses) and has enlarged ventricles on imaging. The doctor should try 
to rule out as many other possible disorders as possible, and consider surgery by carefully 
weighing the risks and potential benefits as well as factoring in the chance for success. 
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